NCM
Nantahala Capital Management Portfolio holdings
AUM
$1.41B
1-Year Return
32.9%
This Quarter Return
-0.66%
1 Year Return
+32.9%
3 Year Return
+104.34%
5 Year Return
+145.08%
10 Year Return
+443.66%
AUM
$1.61B
AUM Growth
-$86.7M
(-5.1%)
Cap. Flow
-$31.7M
Cap. Flow
% of AUM
-1.98%
Top 10 Holdings %
Top 10 Hldgs %
42.81%
Holding
143
New
16
Increased
34
Reduced
36
Closed
12
Top Buys
| 1 |
SC
SANTANDER CONSUMER USA HOLDINGS INC
SC
|
$16.6M |
| 2 |
PAYA
Paya Holdings Inc. Class A Common Stock
PAYA
|
$14.7M |
| 3 |
uniQure
QURE
|
$12.5M |
| 4 |
Semler Scientific
SMLR
|
$12.3M |
| 5 |
The RMR Group
RMR
|
$11.7M |
Top Sells
| 1 |
QADA
QAD Inc.
QADA
|
$81M |
| 2 |
VG
Vonage Holdings Corporation
VG
|
$47.8M |
| 3 |
Codexis
CDXS
|
$16.7M |
| 4 |
Pathward Financial
CASH
|
$15.2M |
| 5 |
iShares Russell 2000 ETF
IWM
|
$12.7M |
Sector Composition
| 1 | Healthcare | 48.38% |
| 2 | Consumer Discretionary | 16.86% |
| 3 | Financials | 8.44% |
| 4 | Industrials | 7.77% |
| 5 | Technology | 5.84% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
51
Scully Royalty
SRL
$80.8M
| $7.15M | 0.25% |
807,089
+54,655
| +7% | +$484K |
|
|
CBAY
52
DELISTED
Cymabay Therapeutics
CBAY
| $6.76M | 0.24% |
+2,000,142
| New | +$6.76M |
|
53
Strata Skin Sciences
SSKN
$7.42M
| $6.7M | 0.24% |
457,581
| – | – |
|
54
ARS Pharmaceuticals
SPRY
$995M
| $6.7M | 0.24% |
1,006,462
-220,169
| -18% | -$1.47M |
|
55
Cidara Therapeutics
CDTX
$1.6B
| $6.69M | 0.24% |
+263,523
| New | +$6.69M |
|
56
Light & Wonder
LNW
$7.48B
| $6.25M | 0.22% |
93,533
+72,706
| +349% | +$4.86M |
|
57
MediaAlpha
MAX
$699M
| $5.72M | 0.2% |
+370,404
| New | +$5.72M |
|
58
Nautilus Biotechnolgy
NAUT
$83.5M
| $5.34M | 0.19% |
1,029,872
-14,395
| -1% | -$74.6K |
|
59
Hyperfine
HYPR
$91.9M
| $5.21M | 0.18% |
+718,637
| New | +$5.21M |
|
|
IMTXW
60
DELISTED
Immatics N.V. Warrants
IMTXW
| $4.7M | 0.17% |
1,071,466
+844,995
| +373% | +$3.71M |
|
61
Soleno Therapeutics
SLNO
$3.71B
| $4M | 0.14% |
651,009
| – | – |
|
|
ARYD
62
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
| $3.96M | 0.14% |
399,248
| – | – |
|
|
ZVO
63
DELISTED
Zovio Inc. Common Stock
ZVO
| $3.79M | 0.13% |
2,980,767
-20,423
| -0.7% | -$25.9K |
|
64
Elicio Therapeutics
ELTX
$188M
| $3.67M | 0.13% |
126,703
+114,851
| +969% | +$3.33M |
|
65
Peloton Interactive
PTON
$3.27B
| $3.66M | 0.13% |
+102,342
| New | +$3.66M |
|
|
HARP
66
DELISTED
Harpoon Therapeutics, Inc. Common Stock
HARP
| $3.59M | 0.13% |
47,547
+5,699
| +14% | +$430K |
|
67
Perella Weinberg Partners
PWP
$1.39B
| $3.58M | 0.13% |
278,140
-202,644
| -42% | -$2.61M |
|
|
FAZE
68
DELISTED
FaZe Holdings Inc. Common Stock
FAZE
| $3.54M | 0.12% |
+349,649
| New | +$3.54M |
|
69
Neuropace
NPCE
$322M
| $3.08M | 0.11% |
305,906
+164,265
| +116% | +$1.66M |
|
70
Payoneer
PAYO
$2.4B
| $2.93M | 0.1% |
398,684
-256,485
| -39% | -$1.88M |
|
71
Wave Life Sciences
WVE
$1.32B
| $2.85M | 0.1% |
907,094
-87,037
| -9% | -$273K |
|
|
BACK
72
DELISTED
IMAC Holdings, Inc. Common Stock
BACK
| $2.73M | 0.1% |
79,736
-741
| -0.9% | -$25.3K |
|
73
Gyre Therapeutics
GYRE
$698M
| $2.52M | 0.09% |
368,221
+43,926
| +14% | +$301K |
|
|
IMV
74
DELISTED
IMV Inc. Common Shares
IMV
| $2.51M | 0.09% |
205,521
-21,282
| -9% | -$260K |
|
|
IDW
75
DELISTED
IDW Media Holdings
IDW
| $2.46M | 0.09% |
1,229,243
-13,000
| -1% | -$26K |
|